CEL SCI CORP - FORM 8-K - EX-23 - EXHIBIT 23 ATTORNEY'S CONSENT - May 2, 2017

Attached files

file filename
EX-99 - EXHIBIT 99 PRESS RELEASE - CEL SCI CORPform8kitem101ex99may-17.txt
EX-10 - EXHIBIT 10 (SSS) SECURITIES PURCHASE AGREEMENT - CEL SCI CORPform8kitem101ex10sssmay-17.txt
EX-5 - EXHIBIT 5 OPINION LETTER - CEL SCI CORPform8kitem101ex5may-17.txt
EX-4 - EXHIBIT 4(R) PLACEMENT AGENT WARRANT (SERIES LL) - CEL SCI CORPform8kitem101ex4rmay-17.txt
EX-4 - EXHIBIT 4(Q) FORM OF WARRANT (SERIES KK) - CEL SCI CORPform8kitem101ex4qmay-17.txt
EX-1 - EXHIBIT 1.1 ENGAGEMENT AGREEMENT - CEL SCI CORPform8kitem101ex11may-17.txt
8-K - FORM 8-K ITEM 1.01 RE SERIES KK WARRANTS - CEL SCI CORPform8kitem101skkwrnt5-17.txt
EX-23 7 form8kitem101ex23may-17.txt EXHIBIT 23 ATTORNEY'S CONSENT EXHIBIT 23 CONSENT OF ATTORNEYS Reference is made to the Registration Statement of CEL-SCI Corporation, whereby the Company proposes to sell shares of its common stock. Reference is also made to Exhibit 5 included as part of this 8-K report relating to the validity of the securities proposed to be sold. We hereby consent to the use of our opinion concerning the validity of the securities proposed to be issued and sold. May 1, 2017 HART & HART, LLC /s/ William T. Hart

CEL SCI CORP Reports